Abstract
MP48-06 ADVERSE EVENTS RELATED TO DAROLUTAMIDE TREATMENT: ANALYSIS OF “REAL LIFE” DATA FROM EUDRAVIGILANCE (EV) AND THE FOOD AND DRUG ADMINISTRATION (FDA) DATABASE ENTRIES
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
